Credential Qtrade Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Credential Qtrade Securities’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,685	Closed	-$1.02M	–	390
2021 Q3	$1.02M	Buy	1,685 +185	+12%	+$115K	0.08%	117
2021 Q2	$838K	Buy	1,500 +420	+39%	+$213K	0.07%	131
2021 Q1	$511K	Buy	+1,080	New	+$526K	0.05%	155
2020 Q1	–	Sell	-13	Closed	-$4.88K	–	327
2019 Q4	$4.88K	Sell	13 -18	-58%	-$6.06K	﹤0.01%	292
2019 Q3	$8.6K	Sell	31 -4	-11%	-$1.18K	﹤0.01%	245
2019 Q2	$11K	Sell	35 -213	-86%	-$70.9K	﹤0.01%	236
2019 Q1	$102K	Sell	248 -172	-41%	-$70.8K	0.02%	192
2018 Q4	$157K	Buy	420 +109	+35%	+$39.9K	0.03%	160
2018 Q3	$126K	Buy	+311	New	+$118K	0.03%	191

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credential Qtrade Securities's REGN Position: Q4 2021 in Review

Credential Qtrade Securities sold out of Regeneron Pharmaceuticals (REGN) in Q4 2021, closing a stake of 1,685 shares — an estimated $1.02M sold.

Credential Qtrade Securities first reported a position in REGN in Q3 2018 and held it in 9 quarters. The position peaked at $1.02M in Q3 2021. 1,078 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Credential Qtrade Securities reported no remaining Regeneron Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Credential Qtrade Securities sold 1,685 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $1.02M.
Credential Qtrade Securities first reported a position in Regeneron Pharmaceuticals in Q3 2018 and held it in 9 quarters.
Credential Qtrade Securities's Regeneron Pharmaceuticals position peaked at $1.02M in Q3 2021.
1,078 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Credential Qtrade Securities's 13F filing for Q4 2021, filed 21 Jul 2025.